Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Julia Rawlings

Concepts (54)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
116
0.670
Why?
Patient Safety
2
2018
287
0.570
Why?
Pharmacy Service, Hospital
1
2018
93
0.530
Why?
Organizational Culture
1
2018
138
0.530
Why?
Remote Consultation
1
2022
46
0.190
Why?
Drug Overdose
1
2022
319
0.150
Why?
Pharmacy
1
2017
32
0.130
Why?
Pharmaceutical Services
1
2017
83
0.130
Why?
Benchmarking
1
2017
175
0.120
Why?
Opioid-Related Disorders
1
2022
480
0.120
Why?
Pharmacists
1
2017
261
0.110
Why?
Colchicine
1
2012
25
0.100
Why?
Gout Suppressants
1
2012
18
0.100
Why?
Gout
1
2012
34
0.100
Why?
Hematologic Diseases
1
2012
61
0.100
Why?
Chemical and Drug Induced Liver Injury
1
2012
132
0.090
Why?
Renal Insufficiency
1
2012
148
0.090
Why?
Attitude of Health Personnel
1
2018
1093
0.080
Why?
Cross-Sectional Studies
2
2018
5039
0.080
Why?
Delivery of Health Care
1
2017
895
0.080
Why?
Surveys and Questionnaires
2
2018
5362
0.070
Why?
Sumatriptan
1
1999
5
0.040
Why?
Health Maintenance Organizations
1
1999
99
0.040
Why?
Colorado
2
2022
4375
0.040
Why?
Migraine Disorders
1
1999
82
0.040
Why?
Pain
1
2022
757
0.030
Why?
Pharmacies
1
2017
37
0.030
Why?
Analgesics, Opioid
1
2022
887
0.030
Why?
Humans
5
2022
128417
0.030
Why?
Practice Patterns, Physicians'
1
2022
1258
0.030
Why?
Counseling
1
2017
382
0.030
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
19
0.030
Why?
Cytochrome P-450 CYP3A
1
2012
65
0.020
Why?
Insurance, Health, Reimbursement
1
2012
95
0.020
Why?
Drug Interactions
1
2012
357
0.020
Why?
Communication
1
2017
838
0.020
Why?
Enzyme Inhibitors
1
2012
809
0.020
Why?
United States
2
2022
13830
0.020
Why?
Prevalence
1
2012
2547
0.020
Why?
Electronic Health Records
1
2012
974
0.010
Why?
Case-Control Studies
1
2012
3328
0.010
Why?
Cohort Studies
1
2012
5388
0.010
Why?
Efficiency
1
1999
92
0.010
Why?
Health Services
1
1999
99
0.010
Why?
Statistics, Nonparametric
1
1999
418
0.010
Why?
Cost of Illness
1
1999
277
0.010
Why?
Young Adult
1
2012
12312
0.010
Why?
Middle Aged
2
2012
30889
0.010
Why?
Adult
2
2012
35299
0.010
Why?
Patient Satisfaction
1
1999
641
0.010
Why?
Aged
1
2012
21953
0.010
Why?
Male
2
2012
62857
0.010
Why?
Female
2
2012
68153
0.010
Why?
Quality of Life
1
1999
2680
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)